Lasers and Flashlamps in the Treatment of Skin Disorders

Rook's Textbook of Dermatology: Eighth Edition

Volumn 4, Issue , 2010, Pages 4137-4152

  Barlow, Richard J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Hair; Laser; Photodynamic therapy; Pigment; Resurfacing; Skin disorders; Vascular

Indexed keywords

EID: 84881312176     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444317633.ch78     Document Type: Chapter

References (108)

1. Einstein A. Zur quantentheorie der Strahlung. Physikalische Gesellschaft Zurich Miteilungen 1916; 18: 47-62.
2. Maiman T. Stimulated optical radiation in ruby. Nature 1960; 187: 493-4.
3. Goldman L. Pathology of the effect of the laser beam on the skin. Nature 1963; 197: 912-4.
4. Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983; 220: 524-7.
5. Waner M, Suen JY. Lasers in head and neck cancer. In: Myers E, Suen JY, eds. Cancer of the Head and Neck, 4th edn. New York: WB Saunders, 2003: 679-92.
6. Altshuler GB, Anderson RR, Manstein D et al. Extended theory of selective photothermolysis. Lasers Surg Med 2001; 29: 416-32.
7. Dierickx C, Alora MB, Dover JS. A clinical overview of hair removal using lasers and light sources. Dermatol Clin 1999; 17: 357-66.
8. Battle EF, Suthamjariya K, Alora M et al. Very long-pulsed (20-2000 ms) diode laser for hair removal on all skin types. Lasers Surg Med 2000; 12 (Suppl.): 21 (Abstract).
9. Anderson RR, Parrish JA. Microvasculature can be selectively damaged using dye lasers: a basic theory and experimental evidence in human skin. Lasers Surg Med 1981; 1: 263-76.
10. Tan OT, Murray S, Kurban AK. Action spectrum of vascular specific injury using pulsed irradiation. J Invest Dermatol 1989; 92: 868-71.
11. Dierickx CC, Casparian JM, Venugopalan V et al. Thermal relaxation of portwine stain vessels probed in vivo: the need for 1-10 millisecond laser pulse treatment. J Invest Dermatol 1995; 105: 709-14.
12. Garden JM, Bakus AD. Laser treatment of portwine stains and haemangiomas. Dermatol Clin 1997; 15: 373-83.
13. Spicer MS, Goldberg DJ. Lasers in dermatology. J Am Acad Dermatol 1996; 34: 1-25.
14. North PE, Waner M, Mizeracki A et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 2001; 137: 559-70.
15. Ashinoff R, Geronemus RG. Capillary hemangiomas and treatment with the flashlamp-pumped pulsed dye laser. Arch Dermatol 1991; 127: 202-5.
16. Landthaler M, Hohenleutner U, Abd El-Raheem T. Laser therapy of childhood haemangiomas. Br J Dermatol 1995; 133: 275-81.
17. Morelli JG, Tan OT, Weston WL. Treatment of ulcerated hemangiomas with the pulsed tunable dye laser. Am J Dis Child 1991; 145: 1062-4.
18. Witman PM, Wagner AM, Scherer K et al. Complications following pulsed dye laser treatment of superficial hemangiomas. Lasers Surg Med 2006; 38: 116-23.
19. Hohenleutner S, Badur-Ganter E, Landthaler M, Hohenleutner U. Long-term results in the treatment of childhood hemangioma with the flashlamp-pumped pulsed dye laser: an evaluation of 617 cases. Lasers Surg Med 2001; 28: 273-7.
20. Batta K, Goodyear HM, Moss C et al. Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis. Lancet 2002; 360: 502-3.
21. Perez J, Pardo J, Gomez C. Vincristine-an effective treatment of corticoidresistant life threatening infantile hemangiomas. Acta Oncol 2002; 41: 197-9.
22. Landthaler M, Hohenleutner U. Laser therapy of vascular lesions. Photodermatol Photoimmunol Photomed 2006; 22: 324-32.
23. Chang C-J, Kelly K, van Gemert MJC, Nelson JS. Comparing the effectiveness of 585 vs 595 nm wavelength pulsed dye laser treatment of port wine stains with cryogen spray cooling. Lasers Surg Med 2002; 31: 352-8.
24. Chang C-J, Nelson JS. Cryogen spray cooling and higher fluence pulsed dye laser treatment improve port-wine stain clearance while minimizing epidermal damage. Dermatol Surg 1999; 25: 767-72.
25. Geronemus RG, Quintana AT, Lou WW, Kauvar AN. High-fluence modified pulsed dye laser photocoagulation with dynamic cooling of port-wine stains in infancy. Arch Dermatol 2000; 136: 942-3.
26. Geronemus RG, Lou WW. Treatment of port-wine stains by variable pulse width pulsed dye laser: a preliminary study. Dermatol Surg 2001; 27: 903-5.
27. Renfro L, Geronemus RG. Anatomical differences of portwine stains in response to treatment with the pulsed dye laser. Arch Dermatol 1993; 129: 182-8.
28. Orten SS, Waner M, Flock S et al. Port wine stains. An assessment of 5 years of treatment. Arch Laryngol Head Neck Surg 1996; 122: 1174-9.
29. Jasim ZF, Handley JM. Treatment of pulsed dye laser-resistant port wine stain birthmarks. J Am Acad Dermatol 2007; 57: 677-82.
30. Childers MA, Franco W, Nelson JS, Aguilar G. Laser surgery of port wine stains using local vacuum pressure: changes in skin morphology and optical properties. Lasers Surg Med 2007; 39: 108-17.
31. Ratz JL, Bailin PL, Levine HL. CO2 laser treatment of portwine stains: a preliminary report. J Dermatol Surg Oncol 1982; 8: 1039-44.
32. Raulin C, Goldman MP, Weiss M, Weiss RA. Treatment of adult port-wine stains using intense pulsed light therapy (Photoderm VL): brief initial clinical report. Dermatol Surg 1997; 23: 594-601.
33. Goldberg DJ, Meine JG. Treatment of facial telangiectases with the diode pumped frequency doubled Q-switched Nd : YAG laser. Dermatol Surg 1998; 24: 828-32.
34. Polla LL, Tan OT, Garden JM, Parrish JA. Tunable pulsed dye laser for the treatment of benign cutaneous vascular ectasia. Dermatologica 1987; 174: 11-17.
35. Astner S, Anderson R. Treating vascular lesions. Dermatol Ther 2005; 18: 267-81.
36. Raulin D, Weiss RA, Schonermark MP. Treatment of essential telangiectasias with an intense pulsed light source (PhotoDerm VL). Dermatol Surg 1997; 23: 941-6.
37. Hsia J, Lowery JA, Zelickson B. Treatment of leg telangiectasia using a long pulse dye laser at 595 nm. Lasers Surg Med 1997; 20: 1-5.
38. Kauvar ANB, Lou WW. Pulsed alexandrite laser for the treatment of leg telangiectasia and reticular veins. Arch Dermatol 2000; 136: 1371-5.
39. Weiss RA, Weiss MA. Early clinical results with a multiple synchronized pulse 1064 nm laser for leg telangiectasias and reticular veins. Dermatol Surg 1999; 25: 399-402.
40. Tan OT, Hurwitz RM, Stafford TJ. Pulsed dye laser treatment of recalcitrant verrucae: a preliminary report. Lasers Surg Med 1993; 13: 127-37.
41. Huilgol SC, Barlow RJ, Markey AC. Failure of pulsed dye laser therapy for resistant verrucae. Clin Exp Dermatol 1996; 21: 93-5.
42. Logan RA, Zachary CB. Outcome of carbon dioxide laser therapy for persistent cutaneous viral warts. Br J Dermatol 1989; 121: 99-105.
43. Alster TS, Williams CM. Treatment of keloid sternotomy scars with the 585 nm flashlamp pumped pulsed dye laser. Lancet 1995; 345: 198-200.
44. Zelickson BD, Mehregan DA, Wendelschfer-Crabb G et al. Clinical and histologic evaluation of psoriatic plaques treated with a flashlamp pulsed dye laser. J Am Acad Dermatol 1996; 35: 64-8.
45. Ammirati CT, Hruza GJ. Treatment of granuloma faciale with the 585 nm pulsed dye laser. Arch Dermatol 1999; 135: 903-5.
46. Chang C-J, Nelson JS, Achauer BM. Q-switched ruby laser treatment of oculodermal melanosis (nevus of Ota). Plast Reconstr Surg 1996; 98: 784-90.
47. Ara G, Anderson RR, Mandel KG et al. Irradiation of pigmented melanoma cells with high intensity pulsed radiation generates acoustic waves and kills cells. Lasers Surg Med 1990; 10: 52-9.
48. Tse Y, Levine VJ, McClain SA, Ashinoff R. The removal of cutaneous pigmentary lesions with the Q-switched ruby laser and the Q-switched neodymium:yttriumaluminium- garnet laser: a comparative study. J Dermatol Surg Oncol 1994; 20: 795-800.
49. Goldstein N, Penoff J, Price N et al. Techniques of removal of tattoos. J Dermatol Surg Oncol 1979; 5: 901-10.
50. Kilmer SL, Anderson RR. Clinical use of the Q-switched ruby and the Q-switched Nd:YAG (1064 and 532 nm) lasers for treatment of tattoos. J Dermatol Surg Oncol 1993; 19: 330-8.
51. Stafford TJ, Tan OT. 510 nm pulsed dye laser and alexandrite crystal laser for the treatment of pigmented lesions and tattoos. Clin Dermatol 1995; 13: 69-73.
52. Goyal S, Arndt KA, Stern RS et al. Laser treatment of tattoos; a prospective, paired comparison study of the Q-switched Nd:YAG (1064 nm), frequency doubled Nd:YAG (532 nm) and Q-switched ruby lasers. J Am Acad Dermatol 1997; 36: 122-5.
53. Kilmer SL, Lee MS, Grevelink JM et al. The Q-switched Nd:YAG laser effectively treats tattoos: a controlled dose-response study. Arch Dermatol 1993; 129: 971-8.
54. Jones A, Roddey P, Orengo I, Rosen T. The Q-switched Nd:YAG laser effectively treats tattoos in darkly pigmented skin. Dermatol Surg 1996; 22: 999-1001.
55. Kilmer SL. Laser treatment of tattoos. Dermatol Clin 1997; 15: 409-17.
56. Taylor CR, Anderson RR. Treatment of benign pigmented epidermal lesions by Q-switched ruby laser. Int J Dermatol 1993; 32: 908-12.
57. Raulin R, Greve B, Grema H. IPL technology: a review. Lasers Surg Med 2003; 32: 78-87.
58. Kagami S, Asahina A, Watanabe R et al. Treatment of 153 Japanese patients with Q-switched alexandrite laser. Lasers-Med-Sci 2007; 22: 159-63.
59. Shimbashi T, Kamide R, Hashimoto T. Long-term follow-up in treatment of solar lentigo and café-au-lait macules with Q-switched ruby laser. Aesthetic Plast Surg 1997; 21: 445-8.
60. Trelles MA, Moreno-Arias GA. Beckers's nevus: erbium:YAG versus Q-switched neodimium:YAG. Lasers Surg Med 2004; 34: 295-7.
61. Lee PK, Rosenberg CN, Tsao H, Sober AJ. Failure of Q-switched ruby laser to eradicate atypical appearing solar lentigo: report of two cases. J Am Acad Dermatol 1998; 38: 314-7.
62. Grevelink JM, Gonzalez S, Bonoan R et al. Treatment of nevus spilus with the Q-switched ruby laser. J Dermatol Surg 1997; 23: 365-70.
63. Goldberg DJ, Nychay SG. Q-switched ruby laser therapy of nevus of Ota. J Dermatol Surg Oncol 1992; 18: 817-21.
64. Alster TS, Williams CM. Treatment of nevus of Ota by the Q-switched alexandrite laser. Dermatol Surg 1995; 21: 592-6.
65. Apfelberg DB. Argon and Q-switched neodymium: yttrium-aluminium-garnet laser treatment of nevus of Ota. Ann Plast Surg 1995; 35: 150-3.
66. Chan HH, Ying SY, Ho WS et al. An in vivo trial comparing the clinical efficacy and complications of Q-switched alexandrite (QS alex) and Q-switched 1064 nm neodymium:yttrium-aluminum-garnet (QS 1064 Nd;YAG) lasers in the treatment of nevus of Ota. Dermatol Surg 2000; 26: 919-22.
67. Chan HH, Leung RS, Ying SY et al. Recurrence of nevus of Ota after successful treatment with Q-switched lasers. Arch Dermatol 2000; 136: 1175-6.
68. Waldorf HA, Kauvar AN, Geronemus RG. Treatment of small and medium congenital nevi with the Q-switched ruby laser. Arch Dermatol 1996; 132: 301-4.
69. Duke D, Byers R, Sober AJ et al. Treatment of benign and atypical naevi with the normal mode ruby laser and the Q-switched ruby laser. Arch Dermatol 1999; 135: 290-6.
70. Taylor CR, Anderson RR. Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol 1994; 20: 592-7.
71. Tannous ZS, Astner S. Utilizing fractional resurfacing in the treatment of therapyresistant melasma. J Cosmet Laser Ther 2005; 7: 39-43.
72. Grekin RC, Shelton RM, Geisse JK, Frieden I. 510 nm pigmented lesion dye laser: its characteristics and clinical uses. J Dermatol Surg Oncol 1993; 18: 341-7.
73. Tsao H, Busam K, Barnhill RN, Dover JS. Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser. Arch Dermatol 1996; 132: 1250-1.
74. Karrer S, Hohenleutner U, Szeimies RM, Landthaler M. Amiodarone-induced pigmentation resolves after treatment with the Q-switched ruby laser. Arch Dermatol 1999; 135: 251-3.
75. Altshuler GB, Anderson RR, Manstein D et al. Extended theory of selective photothermolysis. Lasers Surg Med 2001; 29: 416-32.
76. Campos VB, Dierickx CC, Farinelli WA et al. Hair removal with an 800 nm pulsed diode laser. J Am Acad Dermatol 2000; 43: 442-7.
77. Bencini PL, Luci A, Galimberti M, Ferranti G. Long term epilation with longpulsed neodymium:YAG laser. Dermatol Surg 1999; 25: 175-8.
78. Grossman MC, Dierickx CC, Farinelli WA et al. Damage to hair follicles by normal-mode ruby laser pulses. J Am Acad Dermatol 1996; 35: 889-94.
79. Dierickx CC, Grossman MC, Farinelli WA, Anderson RR. Permanent hair removal by normal-mode ruby laser. Arch Dermatol 1998; 134: 837-42.
80. Eremia S, Li CY, Umar SH, Newman N. Laser hair removal: long term results with a 755 nm alexandrite laser. Dermatol Surg 2001; 27: 920-4.
81. Gold MH, Bell MW, Foster TD, Street S. Long-term epilation using the EpiLight broad band, intense pulsed light hair removal system. Dermatol Surg 1997; 23: 909-13.
82. Lewis AT, Benedetto AV. Lasers in dermatology: Unapproved treatments. Clin in Dermatol 2002; 20: 700-14.
83. Lanigan SW. Incidence of side effects after hair removal. J Am Acad Dermatol 2003; 49: 882-6.
84. Hirsch RJ, Farinelli WA, Laughlin SA et al. Hair growth induced by laser hair removal. Lasers Surg Med 2003; 32: 63.
85. Ross EV, McKinlay JR, Anderson RR. Why does carbon dioxide resurfacing work? Arch Dermatol 1999; 135: 444-54.
86. Manstein D, Herron GS, Sink RK et al. Fractional photothermolysis: a new concept for cutaneous remodelling using microscopic patterns of thermal injury. Lasers Surg Med 2004; 34: 426-38.
87. Hantash BM, Bedi VP, Kapadia B et al. In vivo histological evaluation of a novel ablative fractional resurfacing device. Lasers Surg Med 2007; 39: 96-107.
88. Walsh JJ, Deutsch TF. Pulsed CO2 laser tissue ablation: measurement of the ablation rate. Lasers Surg Med 1988; 8: 264-75.
89. Fitzpatrick RE, Goldman MP. Advances in carbon dioxide laser surgery. Clin Dermatol 1995; 13: 35-47.
90. Apfelberg DB, Maser MR, Lash H et al. Preliminary results of argon and carbon dioxide laser treatment of keloid scars. Lasers Surg Med 1984; 4: 283-90.
91. Bittencourt RCA, Huilgol SC, Seed PT et al. Treatment of angiofibromas with a scanning carbon dioxide laser: a clinicopathologic study with long-term follow-up. J Am Acad Dermatol 2001; 45: 731-5.
92. O'Donoghue NB, Barlow RJ. Laser remodelling of nodular nasal lupus pernio. Clin Exp Dermatol 2005; 31: 27-9.
93. Huilgol SC, Neill S, Barlow RJ. CO2 laser therapy of vulval lymphangiectasia and lymphangioma circumscriptum. Dermatol Surg 2002; 28: 575-7.
94. Ratner D, Tse Y, Marchell N et al. Cutaneous laser resurfacing. J Am Acad Dermatol 1999; 41: 367-89.
95. Abergel RP, Lyons RF, Castel JC et al. Biostimulation of wound healing by laser: experimental approaches in animal models and in fibroblast cultures. J Surg Oncol 1987; 13: 127-33.
96. Howell RM, Cohen DM, Powell GL, Green JG. The use of low energy laser energy to treat aphthous ulcers. Ann Dent 1988; 47: 16-18.
97. Babapour R, Glassberg E, Lask GP. Low-energy laser systems. Clin Dermatol 1995; 13: 87-90.
98. Fisher AMR, Murphee AL, Gomer CJ. Clinical and preclinical photodynamic therapy. Lasers Surg Med 1995; 17: 2-31.
99. Morton CA, Brown SB, Collins S et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology group. Br J Dermatol 2002; 146: 552-67.
100. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B Biol 1990; 6: 143-8.
101. Uehlinger P, Zellweger M, Wagnieres G et al. 5-Aminolaevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX accumulation in cultured cells. J Photochem Photobiol B Biol 2000; 54: 72-80.
102. Soret JL. Recherches sur l'absortion des rayons ultra violets par diverses substances. Arch Sci Phys Nat 1883; 10: 430-85.
103. Gudgin Dickson EF, Pottier RH. On the role of protoporphyrin IX photoproducts in photodynamic therapy. J Photochem Photobiol B Biol 1995; 29: 91-3.
104. De Jode ML, Megilligan JA, Dilkes MG et al. A comparison of novel light sources for photodynamic therapy. Lasers Med Sci 1997; 12: 260-8.
105. Peng Q, Warloe T, Berg K et al. 5 amino-levulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997; 79: 2282-308.
106. Agarwal ML, Clay ME, Harvey EJ et al. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res 1991; 51: 5993-6.
107. Dougherty TJ, Gomer CJ, Henderson BW et al. Photodynamic therapy. J Natl Cancer Inst 1998; 90: 889-905.
108. Kormeili T, Yamauchi PS, Lowe NJ. Topical photodynamic therapy in clinical dermatology. Br J Dermatol 2004; 150: 1061-9.